These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 9192664)
1. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Lehner PJ; Karttunen JT; Wilkinson GW; Cresswell P Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6904-9. PubMed ID: 9192664 [TBL] [Abstract][Full Text] [Related]
2. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. Hewitt EW; Gupta SS; Lehner PJ EMBO J; 2001 Feb; 20(3):387-96. PubMed ID: 11157746 [TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses. Kim Y; Park B; Cho S; Shin J; Cho K; Jun Y; Ahn K PLoS Pathog; 2008 Aug; 4(8):e1000123. PubMed ID: 18688275 [TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826 [TBL] [Abstract][Full Text] [Related]
5. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839 [TBL] [Abstract][Full Text] [Related]
6. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. Hengel H; Esslinger C; Pool J; Goulmy E; Koszinowski UH J Gen Virol; 1995 Dec; 76 ( Pt 12)():2987-97. PubMed ID: 8847504 [TBL] [Abstract][Full Text] [Related]
7. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance. Benz C; Hengel H Virus Genes; 2000; 21(1-2):39-47. PubMed ID: 11022788 [TBL] [Abstract][Full Text] [Related]
8. Dependence of the localization and function of the human cytomegalovirus protein US6 on the transporter associated with antigen processing. Dugan GE; Hewitt EW J Gen Virol; 2009 Sep; 90(Pt 9):2234-8. PubMed ID: 19439551 [TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. Hengel H; Flohr T; Hämmerling GJ; Koszinowski UH; Momburg F J Gen Virol; 1996 Sep; 77 ( Pt 9)():2287-96. PubMed ID: 8811029 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336 [TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6. Dugan GE; Hewitt EW J Virol; 2008 Apr; 82(7):3271-82. PubMed ID: 18199642 [TBL] [Abstract][Full Text] [Related]
14. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625 [TBL] [Abstract][Full Text] [Related]
15. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products. Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106 [TBL] [Abstract][Full Text] [Related]
16. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4 Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T Front Immunol; 2018; 9():1129. PubMed ID: 29887865 [TBL] [Abstract][Full Text] [Related]
17. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes. Oosten LE; Koppers-Lalic D; Blokland E; Mulder A; Ressing ME; Mutis T; van Halteren AG; Wiertz EJ; Goulmy E Int Immunol; 2007 Sep; 19(9):1115-22. PubMed ID: 17855435 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma. Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627 [TBL] [Abstract][Full Text] [Related]
19. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437 [TBL] [Abstract][Full Text] [Related]